{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T23:08:26Z","timestamp":1773184106719,"version":"3.50.1"},"reference-count":26,"publisher":"BMJ","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"published-print":{"date-parts":[[1997,6,1]]},"DOI":"10.1136\/jnnp.62.6.622","type":"journal-article","created":{"date-parts":[[2008,11,10]],"date-time":"2008-11-10T22:20:59Z","timestamp":1226355659000},"page":"622-625","source":"Crossref","is-referenced-by-count":28,"title":["[18F]fluorodopa PET shows striatal dopaminergic dysfunction in juvenile neuronal ceroid lipofuscinosis."],"prefix":"10.1136","volume":"62","author":[{"given":"H M","family":"Ruottinen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J O","family":"Rinne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Haaparanta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"Solin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V J","family":"Oikonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Jarvela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Santavuori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","first-page":"588","article-title":"The neuronal ceroid-lipofuscinoses (Batten-Vogt syndrome)","volume-title":"Handbook of clinical neurology. Vol X","author":"Zeman, W.; Donohue, S.; Dyken, P.; Green, J.","year":"1970","unstructured":"Zeman W, Donohue S, Dyken P, Green J. The neuronal ceroid-lipofuscinoses (Batten-Vogt syndrome). In: Vinken P, Bruyn GW, eds. Handbook of clinical neurology. Vol X. Amsterdam: North Holland, 1970:588-679."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ajmg.1320310606","article-title":"Batten disease: past, present, and future","volume":"5","author":"Rider, J.A.; Rider, D.L.","year":"1988","unstructured":"Rider JA, Rider DL. Batten disease: past, present, and future. AmJMed Genet 1988;5(suppl):21-6.","journal-title":"AmJMed Genet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1600-0404.1985.tb03178.x","article-title":"Antioxidant treatment in Spielmeyer-Sjogren's disease","volume":"71","author":"Santavuori, P.; Westermarck, T.; Rapola, J.","year":"1985","unstructured":"Santavuori P, Westermarck T, Rapola J, et al. Antioxidant treatment in Spielmeyer-Sjogren's disease. Acta Neurol Scand 1985;71:136-45.","journal-title":"Acta Neurol Scand"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0092-8674(95)90274-0","article-title":"The International Batten Disease Consortium. Isolation of a novel gene underlying Batten disease, CLN3","volume":"82","year":"1995","unstructured":"The International Batten Disease Consortium. Isolation of a novel gene underlying Batten disease, CLN3. Cell 1995; 82:949-57.","journal-title":"Cell"},{"key":"ref_5","first-page":"273","article-title":"Comparison of the clinical courses in patients with juvenile neuronal ceroid lipofuscinosis receiving antioxidant treatment and those without antioxidant treatment","volume":"266","author":"Santavuori, P.; Heiskala, H.; Autti, T.; Johansson, E.; Westermarck, T.","year":"1990","unstructured":"Santavuori P, Heiskala H, Autti T, Johansson E, Westermarck T. Comparison of the clinical courses in patients with juvenile neuronal ceroid lipofuscinosis receiving antioxidant treatment and those without antioxidant treatment. Adv Exp Med Biol 1990;266:273-82.","journal-title":"Adv Exp Med Biol"},{"key":"ref_6","first-page":"265","article-title":"Experience over 17 years with antioxidant treatment in Spielmeyer-Sjogren disease","volume":"5","author":"Santavuori, P.; Heiskala, H.; Westermarck, T.; Sainio, K.; Moren, R.","year":"1988","unstructured":"Santavuori P, Heiskala H, Westermarck T, Sainio K, Moren R. Experience over 17 years with antioxidant treatment in Spielmeyer-Sjogren disease. Am J Med Genet 1988; 5(suppl):265-74.","journal-title":"Am J Med Genet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1136\/jnnp.53.12.1063","article-title":"Neuronal ceroid-lipofuscinosis: preferential metabolic alterations in thalamus and posterior association cortex demonstrated by PET","volume":"53","author":"AG, De Volder; S, Cirelli; de Barsy Th","year":"1990","unstructured":"De Volder AG, Cirelli S, de Barsy Th, et al. Neuronal ceroid-lipofuscinosis: preferential metabolic alterations in thalamus and posterior association cortex demonstrated by PET. J Neurol Neurosurg Psychiatry 1990;53: 1063-7.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0303-8467(82)90062-2","article-title":"Anti-parkinson drugs in the Batten-Spielmeyer-Vogt syndrome; a pilot trial","volume":"84","year":"1982","unstructured":"Zweije-Hofman IL, van der Zee HJ, van Nieuwenhuizen 0. Anti-parkinson drugs in the Batten-Spielmeyer-Vogt syndrome; a pilot trial. Clin Neurol Neurosurg 1982;84:101-5.","journal-title":"Clin Neurol Neurosurg"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0046-8177(84)80034-9","article-title":"Suction biopsy of rectal mucosa in the diagnosis of infantile and juvenile types of neuronal ceroid lipofuscinoses","volume":"15","author":"Rapola, J.; Santavuori, P.; Savilahti, E.","year":"1984","unstructured":"Rapola J, Santavuori P, Savilahti E. Suction biopsy of rectal mucosa in the diagnosis of infantile and juvenile types of neuronal ceroid lipofuscinoses. Hum Pathol 1984;15: 352-60.","journal-title":"Hum Pathol"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/jmg.33.12.1041","article-title":"Rapid diagnostic test for the major mutation underlying Batten disease","volume":"33","author":"Jarvela, I.; Mitchison, H.M.; Munroe, P.B.; O'Rawe, A.M.; Mole, S.E.; Syvanen, A.-C.","year":"1996","unstructured":"Jarvela I, Mitchison HM, Munroe PB, O'Rawe AM, Mole SE, Syvanen A-C. Rapid diagnostic test for the major mutation underlying Batten disease. JMed Genet 1996;33: 1041-2.","journal-title":"JMed Genet"},{"key":"ref_11","first-page":"153","article-title":"Members of the LPDRS Development Committee. Unified Parkinson's disease rating scale","volume-title":"developments in Parkinson's disease","author":"Fahn, S.; Elton, R.L.","year":"1987","unstructured":"Fahn S, Elton RL, Members of the LPDRS Development Committee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB, eds. Recent developments in Parkinson's disease. Vol II. Florham Park, NJ: Macmillan Healthcare Information, 1987: 153-63."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF02251225","article-title":"Striatal ['1F]fluorodopa utilization after COMT inhibition with entacapone studied with PET in advanced Parkinson's disease","volume":"10","author":"Ruottinen, H.M.; Rinne, J.O.; Ruotsalainen, U.H.","year":"1995","unstructured":"Ruottinen HM, Rinne JO, Ruotsalainen UH, et al. Striatal ['1F]fluorodopa utilization after COMT inhibition with entacapone studied with PET in advanced Parkinson's disease. JfNeural Transm [P-D Sect] 1995;10:91-106.","journal-title":"JfNeural Transm [P-D Sect]"},{"key":"ref_13","first-page":"69","article-title":"A new method for the production of electrophilic F-18 starting from aqueous [F-18]fluoride","volume":"34","author":"abstract","year":"1993","unstructured":"Bergman J, Killman K-M, Solin 0, DeJesus OT, Oakes TR, Nickles RJ. A new method for the production of electrophilic F-18 starting from aqueous [F-18]fluoride [abstract]. J Nucl Med 1993;34:69.","journal-title":"J Nucl Med"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/0883-2889(92)90217-3","article-title":"Regioselective radiofluorodestannylation with ['8F]F2 and ['8F]CH, COOF: a high yield synthesis of 6-[\"8F]fluoro-Ldopa","volume":"43","author":"Namavari, M.; Bishop, A.; Satyamurthy, N.; Bida, G.; Barrio, JR","year":"1992","unstructured":"Namavari M, Bishop A, Satyamurthy N, Bida G, Barrio JR. Regioselective radiofluorodestannylation with ['8F]F2 and ['8F]CH,COOF: a high yield synthesis of 6-[\"8F]fluoro-Ldopa. Appl Radiat Isot 1992;43:989-96.","journal-title":"Appl Radiat Isot"},{"key":"ref_15","first-page":"476","article-title":"Electrophilic synthesis of 6-[\"8F]fluoro-L-dopa, starting from aqueous [\"IFl-fluoride","volume":"35","author":"abstract","year":"1994","unstructured":"Bergman J, Haaparanta M, Lehikoinen P, Solin 0. Electrophilic synthesis of 6-[\"8F]fluoro-L-dopa, starting from aqueous [\"IFl-fluoride [abstract]. Journal of LabeUled Compounds and Radiopharmaceuticals 1994;35:476-7.","journal-title":"Journal of LabeUled Compounds and Radiopharmaceuticals"},{"key":"ref_16","article-title":"A colour atlas of the human brain","author":"Aquilonius, S.-M.; Eckernas, S.-A.","year":"1980","unstructured":"Aquilonius S-M, Eckernas S-A. A colour atlas of the human brain. Stockholm, Sweden: Esselte studium, 1980."},{"key":"ref_17","first-page":"584","article-title":"Blasberg RG. Graphical evaluation of blood-tobrain transfer constants from multiple-time uptake data. Generalizations. JfCereb Blood Flow Metab","volume":"5","author":"Patlak, C.S.","year":"1985","unstructured":"Patlak CS, Blasberg RG. Graphical evaluation of blood-tobrain transfer constants from multiple-time uptake data. Generalizations. JfCereb Blood Flow Metab 1985;5:584-90."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/brain\/113.5.1539","article-title":"The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET","volume":"113","author":"Brooks, D.J.; Salmon, E.P.; Mathias, C.J.","year":"1990","unstructured":"Brooks DJ, Salmon EP, Mathias CJ, et al. The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET. Brain 1990;113: 1539-52.","journal-title":"Brain"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF01250373","article-title":"Brain kinetics of L-[\/3'lC]DOPA in humans studied by positron emission tomography","volume":"86","author":"Hartvig, P.; Agren, H.; Reibring, L.","year":"1991","unstructured":"Hartvig P, Agren H, Reibring L, et al. Brain kinetics of L-[\/3'lC]DOPA in humans studied by positron emission tomography. JNeural Transm [Gen Sect] 1991;86:25-41.","journal-title":"JNeural Transm [Gen Sect]"},{"key":"ref_20","series-title":"Proceedings of Nordic Meeting on Spielmeyer-Vogt Disease. Almasa","first-page":"15","article-title":"The management of Spielmeyer-Sj6gren disease","author":"Santavuori, P.","year":"1987","unstructured":"Santavuori P. The management of Spielmeyer-Sj6gren disease. In: Uvebrandt P, Svensson H, eds. Proceedings of Nordic Meeting on Spielmeyer-Vogt Disease. Almasa, Sweden: Society for Visually Handicapped, Sweden, 1987: 15-17."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/brain\/117.5.1085","article-title":"Spielmeyer-Vogt (Batten, Spielmeyer-Sjogren) disease. Distinctive patterns of cerebral glucose utilization","volume":"117","author":"Philippart, M.; Messa, C.; Chugani, H.T.","year":"1994","unstructured":"Philippart M, Messa C, Chugani HT. Spielmeyer-Vogt (Batten, Spielmeyer-Sjogren) disease. Distinctive patterns of cerebral glucose utilization. Brain 1994;117: 1085-92.","journal-title":"Brain"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0387-7604(94)90008-6","article-title":"Positron emission tomography in neuronal ceroid lipofuscinosis (Jansky-Bielschowsky disease): a case report","volume":"16","author":"Iannetti, P.; Messa, C.; Spalice, A.; Lucignani, G.; Fazio, F.","year":"1994","unstructured":"Iannetti P, Messa C, Spalice A, Lucignani G, Fazio F. Positron emission tomography in neuronal ceroid lipofuscinosis (Jansky-Bielschowsky disease): a case report. Brain Dev 1994;16:459-62.","journal-title":"Brain Dev"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/ana.410260407","article-title":"Nigrostriatal function in humans studied with positron emission tomography","volume":"26","author":"Martin, W.R.W.; Palmer, M.R.; Patlak, C.S.; Calne, D.B.","year":"1989","unstructured":"Martin WRW, Palmer MR, Patlak CS, Calne DB. Nigrostriatal function in humans studied with positron emission tomography. Ann Neurol 1989;26:535-42.","journal-title":"Ann Neurol"},{"key":"ref_24","first-page":"28","article-title":"Striatal function in normal aging: implications for Parkinson's disease","author":"Sawle, G.V.; Colebatch, J.G.; Shah, A.","year":"1990","unstructured":"Sawle GV, Colebatch JG, Shah A, et al. Striatal function in normal aging: implications for Parkinson's disease. Ann Neurol 1990;28-799-804.","journal-title":"Ann Neurol"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/jcbfm.1993.110","article-title":"Striatal \"IF-DOPA uptake: absence of an aging effect","volume":"13","author":"Eidelberg, D.; Takikawa, S.; Dhawan, V.","year":"1993","unstructured":"Eidelberg D, Takikawa S, Dhawan V, et al. Striatal \"IF-DOPA uptake: absence of an aging effect. _J Cereb Blood Flow Metab 1993;13:881-8.","journal-title":"_J Cereb Blood Flow Metab"},{"key":"ref_26","first-page":"476","article-title":"MRI of neuronal ceroid lipofuscinosis 1. Cranial MRI of 30 patients with juvenile neuronal ceroid lipofuscinosis","volume":"38","author":"Autti, T.; Raininko, R.; Vanhanen, S.-L.; Santavuori, P.","year":"1996","unstructured":"Autti T, Raininko R, Vanhanen S-L, Santavuori P. MRI of neuronal ceroid lipofuscinosis 1. Cranial MRI of 30 patients with juvenile neuronal ceroid lipofuscinosis. Neuroradiology 1996;38:476-82.","journal-title":"Neuroradiology"}],"container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp.62.6.622","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T02:56:19Z","timestamp":1601088979000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp.62.6.622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,6,1]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1997,6,1]]}},"URL":"https:\/\/doi.org\/10.1136\/jnnp.62.6.622","relation":{},"ISSN":["0022-3050"],"issn-type":[{"value":"0022-3050","type":"print"}],"subject":[],"published":{"date-parts":[[1997,6,1]]}}}